Displaying drugs 14876 - 14900 of 14943 in total
Trifluperidol
Experimental
Methoxyamine
Investigational
Brostallicin
Investigational
R-348
Investigational
FavId
FavId, is an active immunotherapy that is based upon unique genetic information extracted from a patient's tumor.
Investigational
4-Nitrocatechol
Experimental
3,5-Dinitrocatechol
Experimental
Pyrrolnitrin
Experimental
KB002
KB002 is an engineered human IgG1k antibody engineered human. It is developed for the treatment of autoimmune diseases, initially rheumatoid arthritis.
Investigational
UC-781
UC-781 is a thiocarboxanilide non-nucleoside reverse transcriptase inhibitor (NNRTI). It is a topical microbicide targeted against the AIDS virus.
Investigational
Etonitazene
Experimental
Illicit
AR-AO-14418
Experimental
ISIS 113715
ISIS 113715 is our second-generation antisense inhibitor of protein tyrosine phosphatase 1b, or PTP‑1b, for the treatment of type 2 diabetes. In early trials, ISIS 113715 induced statistically significant improvements in multiple measures of glucose control along with statistically significant
reductions in LDL-cholesterol.
Investigational
Displaying drugs 14876 - 14900 of 14943 in total